R Kato Selected Research

R Kato Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 09/2000
3	Sarcopenia 01/2022 - 01/2020
3	Erectile Dysfunction 01/2009 - 05/2006
2	Malnutrition (Nutritional Deficiencies) 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2018 - 03/2016
2	Staphylococcal Food Poisoning 09/2016 - 06/2015
2	Inflammation (Inflammations) 08/2010 - 04/2010
2	Stomach Neoplasms (Stomach Cancer) 04/2000 - 02/2000
1	Guillain-Barre Syndrome 10/2022
1	Fecal Incontinence 01/2022
1	Pressure Ulcer (Bedsore) 01/2021
1	Hoarseness 01/2021
1	Aphasia (Dysphasia) 01/2021
1	Dysarthria (Spastic Dysarthria) 01/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Body Weight (Weight, Body) 01/2018
1	Ischemia 01/2018
1	Reperfusion Injury 01/2018
1	Periodontitis 06/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015
1	Pericarditis 07/2015
1	Vasculitis (Vasculitides) 07/2015
1	XX Disorders of Sex Development 46 (Female Pseudohermaphroditism) 01/2013
1	Virilism (Virilization) 01/2013
1	Disease Progression 01/2013
1	Hyperinsulinism (Hyperinsulinemia) 08/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2010
1	Type 2 Diabetes Mellitus (MODY) 04/2009
1	Insulin Resistance 04/2009
1	Aspergillosis 07/2008
1	Bacterial Pneumonia 07/2008
1	Hemorrhagic Cystitis 07/2008
1	Infections 07/2008
1	Bacteremia 07/2008
1	Bronchiolitis Obliterans Syndrome 07/2008
1	Moyamoya Disease (Moya-Moya Disease) 04/2006
1	Hernia (Hernias) 11/2005
1	Monosomy 12/2001
1	Glaucoma 12/2001
1	Trisomy (Trisomies) 12/2001
1	Pyelonephritis 12/2001

Drug/Important Bio-Agent (IBA)

3	oxidized low density lipoproteinIBA 06/2017 - 04/2010
2	Serum AlbuminIBA 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2022 - 01/2021
2	EnzymesIBA 03/2016 - 02/2000
2	Prednisolone (Predate)FDA LinkGeneric 07/2015 - 07/2008
2	Methylprednisolone FDA LinkGeneric 07/2015 - 09/2000
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2009 - 09/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2008 - 04/2001
1	BNT162 VaccineIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	F 4 (F-4)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Carbon MonoxideIBA 01/2018
1	HydrogenIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CytokinesIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Heme Oxygenase-1IBA 01/2018
1	Apolipoproteins B (ApoB)IBA 06/2017
1	CoagulaseIBA 09/2016
1	TransferasesIBA 03/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2016
1	Uridine Diphosphate (UDP)IBA 03/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2015
1	spleen fibrinolytic proteinase (human) (SFP)IBA 06/2015
1	Enterotoxins (Enterotoxin)IBA 06/2015
1	SteroidsIBA 01/2013
1	gosha-jinki-ganIBA 08/2011
1	Sucrose (Saccharose)IBA 08/2011
1	nedaplatinIBA 01/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010
1	alpha-AmylasesIBA 04/2009
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2009
1	Starch (Cornstarch)IBA 04/2009
1	AdiponectinIBA 04/2009
1	NeurturinIBA 01/2009
1	Imatinib Mesylate (Gleevec)FDA Link 07/2008
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2008
1	Sildenafil Citrate (Viagra)FDA Link 05/2006
1	Anesthetics (Anesthetic Agents)IBA 04/2006
1	BariumIBA 11/2005
1	SilverIBA 12/2001

Therapy/Procedure

4	Therapeutics 07/2015 - 01/2000
3	Drug Therapy (Chemotherapy) 12/2001 - 02/2000
1	Enteral Nutrition (Feeding, Tube) 01/2022
1	Gastrostomy 01/2022
1	Polypharmacy 01/2021
1	Activities of Daily Living (ADL) 01/2021
1	Central Venous Catheters 07/2008
1	Hematopoietic Stem Cell Transplantation 07/2008
1	Cesarean Section (Caesarean Section) 04/2006
1	Anesthesia 04/2006